Cargando…
Tuberculosis pathophysiology and anti-VEGF intervention
The pathophysiological understanding of tuberculosis is growing, and with this growth comes the possibility of applying established pharmaceuticals in new ways. These new ways interlude with the many mechanisms by which the intracellular pathogen, Mycobacterium tuberculosis, thrives in its human hos...
Autor principal: | Maison, David P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790470/ https://www.ncbi.nlm.nih.gov/pubmed/35111979 http://dx.doi.org/10.1016/j.jctube.2022.100300 |
Ejemplares similares
-
Role of VEGF in Kidney Development, Microvascular Maintenance and Pathophysiology of Renal Disease
por: Kim, Byung-Soo, et al.
Publicado: (2003) -
The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016) -
Anti-VEGF and Beyond
por: Bertelmann, T., et al.
Publicado: (2017) -
Anti-VEGF drugs in the prevention of blindness
por: Yorston, David
Publicado: (2014) -
Anti-VEGF intervention in neovascular AMD: benefits and risks restated as natural frequencies
por: Clearkin, Louis, et al.
Publicado: (2019)